Iodide

Iodide

SCHEMBL28654692

CNCCI.I

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7053928 0.96
Bromide SCHEMBL28667693 0.92
Hydrochloric Acid SCHEMBL28658437 0.92
SCHEMBL295853 0.81
Hydrochloric Acid SCHEMBL19922518 0.79
Sulfuric Acid SCHEMBL28672831 0.78 CA5A (0.33)
SCHEMBL18054741 0.76
Iodide SCHEMBL7118709 0.74
SCHEMBL14536485 0.72 EPHX1 (0.43)
SCHEMBL13634251 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113563255-B Preparation method of remifloxacin intermediate 成都倍特药业股份有限公司 2023-08-18 CN claimed
CN-113563255-A Preparation method of Rifloxacin intermediate 成都倍特药业股份有限公司 2021-10-29 CN claimed
CN-113563255-B Preparation method of remifloxacin intermediate 成都倍特药业股份有限公司 2023-08-18 CN disclosed
CN-113563255-A Preparation method of Rifloxacin intermediate 成都倍特药业股份有限公司 2021-10-29 CN disclosed